Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Oligodendroglioma
ADR ID BADD_A07506
ADR Hierarchy
17      Nervous system disorders
17.20      Nervous system neoplasms malignant and unspecified NEC
17.20.01      Nervous system neoplasms unspecified malignancy NEC
17.20.01.008      Oligodendroglioma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.30      Nervous system neoplasms malignant and unspecified NEC
16.30.01      Nervous system neoplasms unspecified malignancy NEC
16.30.01.008      Oligodendroglioma
Description A relatively slow-growing glioma that is derived from oligodendrocytes and tends to occur in the cerebral hemispheres, thalamus, or lateral ventricle. They may present at any age, but are most frequent in the third to fifth decades, with an earlier incidence peak in the first decade. Histologically, these tumors are encapsulated, relatively avascular, and tend to form cysts and microcalcifications. Neoplastic cells tend to have small round nuclei surrounded by unstained nuclei. The tumors may vary from well-differentiated to highly anaplastic forms. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2052; Adams et al., Principles of Neurology, 6th ed, p655) [MeSH]
MedDRA Code 10030286
MeSH ID D009837
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Oligodendroglioma | Oligodendrogliomas | Mixed Oligodendroglioma-Astrocytoma | Mixed Oligodendroglioma Astrocytoma | Mixed Oligodendroglioma-Astrocytomas | Oligodendroglioma-Astrocytoma, Mixed | Oligodendroglioma-Astrocytomas, Mixed | Mixed Oligodendroglioma-Ependymoma | Mixed Oligodendroglioma Ependymoma | Mixed Oligodendroglioma-Ependymomas | Oligodendroglioma-Ependymoma, Mixed | Oligodendroglioma-Ependymomas, Mixed | Oligodendroglioma, Adult | Adult Oligodendroglioma | Adult Oligodendrogliomas | Oligodendrogliomas, Adult | Oligodendroglioma, Childhood | Childhood Oligodendroglioma | Childhood Oligodendrogliomas | Oligodendrogliomas, Childhood | Oligodendroglioma, Well-Differentiated | Oligodendroglioma, Well Differentiated | Oligodendrogliomas, Well-Differentiated | Well-Differentiated Oligodendrogliomas | Well-Differentiated Oligodendroglioma | Well Differentiated Oligodendroglioma | Anaplastic Oligodendroglioma | Anaplastic Oligodendrogliomas | Oligodendroglioma, Anaplastic | Oligodendrogliomas, Anaplastic | Oligodendroblastoma | Oligodendroblastomas
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01834Prednisone0.000009%
BADD_D02150Temozolomide0.000168%
The 1th Page    1    Total 1 Pages